“My name is General Thomas Calloway,” the recording began.
“This statement concerns Operation Lantern, the Kestrel-9 exposure, and an ongoing effort to destroy the surviving medical evidence.”
Victor stepped backward.
One of the agents stopped him.
On the screen, Calloway explained that Operation Lantern had recovered stolen chemical weapons from a militia-controlled research site.
During the extraction, a storage container ruptured.
The team had been ordered to use Kestrel-9, an experimental antidote that had not completed human safety testing.
The compound saved lives that night.
It also caused delayed neurological and cardiac injuries in dozens of soldiers and support personnel.
Kestrel Dynamics learned of the complications within two years.
Instead of reporting them, company executives altered follow-up data and pressured military officials to classify the medical findings with the mission.
The classification protected operational secrets.
It also buried the victims.
Calloway had spent years trying to separate the medical evidence from the tactical files so survivors could receive treatment without exposing national security information.
Each attempt was blocked.
Then he discovered that Morrow Biodyne was preparing to sell a modified version of Kestrel-9 to civilian emergency agencies.
The company needed the old complication reports erased before regulators reviewed the product.
“Victor Hale was recruited because his hospital houses one of the last independent data archives containing treatment records from Lantern survivors,” Calloway said on the video.
“He was paid to identify those survivors, remove medical alerts, and make any resulting injuries appear unrelated.”
The recording changed to security footage from Calloway’s hospital room.
Victor entered alone on the night of the admission.
He opened the general’s chart, photographed the restricted warning, and made a call.
The audio was clear.
“The alert is here,” Victor said.
“The nurse may be a problem.
Bennett.
She keeps asking why the rhythm changed.”
A distorted voice answered, “Remove her access before Calloway wakes up.
Then transfer him.”
Victor asked, “And the drive?”
“Find it.”
The video ended.
Nobody in the ICU spoke.
Victor looked at the screen, then at the witnesses behind the glass.
He could no longer pretend the room belonged to him.
“That footage was manipulated,” he said.
Voss closed the laptop.
“You can make that argument through counsel.”
“I did not poison anyone.”
“No one has accused you of poisoning him,” Voss said.
Victor realized his mistake too late.
Dr.
Price stared at him.
“Poison?”
Voss’s expression sharpened.
“Why did you use that word, Mr.
Hale?”
Victor’s mouth opened, but nothing came out.
I looked at the infusion pump.
The dangerous drug interaction explained the arrhythmia, but not the general’s sudden fever, confusion, or rapid decline.
Those symptoms had begun before the antibiotic was ordered.
“Draw another toxicology panel,” I said.
“Use a sealed chain of custody.
Compare it with his admission sample.”
Victor shook his head.
